Lester Tsai1, Christopher Ma2, Parambir S Dulai1, Larry J Prokop3, Samuel Eisenstein4, Sonia L Ramamoorthy4, Brian G Feagan5, Vipul Jairath5, William J Sandborn1, Siddharth Singh6. 1. Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California. 2. Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada. 3. Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota. 4. Division of Colorectal Surgery, Department of Surgery, University of California San Diego, La Jolla, California. 5. Division of Gastroenterology, University of Western Ontario, London, Ontario, Canada. 6. Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California; Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California. Electronic address: sis040@ucsd.edu.
Abstract
BACKGROUND & AIMS: We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn's disease (CD), focusing on contemporary risks. METHODS: Through a systematic review until September 3, 2019, we identified population-based cohort studies that reported patient-level cumulative risk of surgery in patients with UC and CD. We evaluated overall and contemporary risk (after 2000) of surgery and analyzed time trends through mixed-effects meta-regression. RESULTS: In patients with UC (26 studies), the overall 1-, 5-, and 10-year risks of colectomy was 4.0% (95% CI, 3.3-5.0), 8.8% (95% CI, 7.7-10.0), and 13.3% (95% CI, 11.3-15.5), respectively, with a decrease in risk over time (P < .001). Corresponding contemporary risks were 2.8% (95% CI, 2.0-3.9), 7.0% (95% CI, 5.7-8.6), and 9.6% (95% CI, 6.3-14.2), respectively. In patients with CD (22 studies), the overall 1-, 5-, and 10-year risk of surgery was 18.7% (95% CI, 15.0-23.0), 28.0% (95% CI, 24.0-32.4), and 39.5% (95% CI, 33.3-46.2), respectively, with a decrease in risk over time (P < .001). Corresponding contemporary risks were 12.3% (95% CI, 10.8-14.0), 18.0% (95% CI, 15.4-21.0), and 26.2% (95% CI, 23.4-29.4), respectively. In a meta-analysis of 8 studies in patients with CD with prior resection, the cumulative risk of a second resection at 5 and 10 years after the first resection was 17.7% (95% CI, 13.5-22.9) and 31.3% (95% CI, 24.1-39.6), respectively. CONCLUSIONS: Patient-level risks of surgery have decreased significantly over time, with a 5-year cumulative risk of surgery of 7.0% in UC and 18.0% in CD in contemporary cohorts. This decrease may be related to early detection and/or better treatment.
BACKGROUND & AIMS: We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn's disease (CD), focusing on contemporary risks. METHODS: Through a systematic review until September 3, 2019, we identified population-based cohort studies that reported patient-level cumulative risk of surgery in patients with UC and CD. We evaluated overall and contemporary risk (after 2000) of surgery and analyzed time trends through mixed-effects meta-regression. RESULTS: In patients with UC (26 studies), the overall 1-, 5-, and 10-year risks of colectomy was 4.0% (95% CI, 3.3-5.0), 8.8% (95% CI, 7.7-10.0), and 13.3% (95% CI, 11.3-15.5), respectively, with a decrease in risk over time (P < .001). Corresponding contemporary risks were 2.8% (95% CI, 2.0-3.9), 7.0% (95% CI, 5.7-8.6), and 9.6% (95% CI, 6.3-14.2), respectively. In patients with CD (22 studies), the overall 1-, 5-, and 10-year risk of surgery was 18.7% (95% CI, 15.0-23.0), 28.0% (95% CI, 24.0-32.4), and 39.5% (95% CI, 33.3-46.2), respectively, with a decrease in risk over time (P < .001). Corresponding contemporary risks were 12.3% (95% CI, 10.8-14.0), 18.0% (95% CI, 15.4-21.0), and 26.2% (95% CI, 23.4-29.4), respectively. In a meta-analysis of 8 studies in patients with CD with prior resection, the cumulative risk of a second resection at 5 and 10 years after the first resection was 17.7% (95% CI, 13.5-22.9) and 31.3% (95% CI, 24.1-39.6), respectively. CONCLUSIONS: Patient-level risks of surgery have decreased significantly over time, with a 5-year cumulative risk of surgery of 7.0% in UC and 18.0% in CD in contemporary cohorts. This decrease may be related to early detection and/or better treatment.
Authors: Marianne K Vester-Andersen; Ida Vind; Michelle V Prosberg; Bo G Bengtsson; Thomas Blixt; Pia Munkholm; Mikael Andersson; Tine Jess; Flemming Bendtsen Journal: J Crohns Colitis Date: 2014-08-22 Impact factor: 9.071
Authors: Alexandra D Frolkis; Jonathan Dykeman; María E Negrón; Jennifer Debruyn; Nathalie Jette; Kirsten M Fiest; Talia Frolkis; Herman W Barkema; Kevin P Rioux; Remo Panaccione; Subrata Ghosh; Samuel Wiebe; Gilaad G Kaplan Journal: Gastroenterology Date: 2013-07-27 Impact factor: 22.682
Authors: Anders Rönnblom; Tommy Holmström; Hans Tanghöj; Urban Karlbom; Mari Thörn; Daniel Sjöberg Journal: Scand J Gastroenterol Date: 2016-06-29 Impact factor: 2.423
Authors: Geoffrey C Nguyen; Fred Saibil; A Hillary Steinhart; Qi Li; Jill M Tinmouth Journal: Am J Gastroenterol Date: 2012-07-31 Impact factor: 10.864
Authors: Jean-Frederic Colombel; Remo Panaccione; Peter Bossuyt; Milan Lukas; Filip Baert; Tomas Vaňásek; Ahmet Danalioglu; Gottfried Novacek; Alessandro Armuzzi; Xavier Hébuterne; Simon Travis; Silvio Danese; Walter Reinisch; William J Sandborn; Paul Rutgeerts; Daniel Hommes; Stefan Schreiber; Ezequiel Neimark; Bidan Huang; Qian Zhou; Paloma Mendez; Joel Petersson; Kori Wallace; Anne M Robinson; Roopal B Thakkar; Geert D'Haens Journal: Lancet Date: 2017-10-31 Impact factor: 79.321
Authors: V Chhaya; S Saxena; E Cecil; S Chatu; V Subramanian; V Curcin; A Majeed; R C Pollok Journal: Aliment Pharmacol Ther Date: 2014-11-10 Impact factor: 8.171
Authors: Caroline Nordenvall; Oda Rosvall; Matteo Bottai; Åsa H Everhov; Petter Malmborg; Karin E Smedby; Anders Ekbom; Johan Askling; Jonas F Ludvigsson; Pär Myrelid; Ola Olén Journal: J Crohns Colitis Date: 2018-01-24 Impact factor: 9.071
Authors: Michiel T J Bak; Marit F E Ruiterkamp; Oddeke van Ruler; Marjo J E Campmans-Kuijpers; Bart C Bongers; Nico L U van Meeteren; C Janneke van der Woude; Laurents P S Stassen; Annemarie C de Vries Journal: World J Gastroenterol Date: 2022-06-14 Impact factor: 5.374
Authors: Margaret Walshe; Shadi Nayeri; Jiayi Ji; Cristian Hernandez-Rocha; Ksenija Sabic; Liangyuan Hu; Mamta Giri; Shikha Nayar; Steven Brant; Dermot P B McGovern; John D Rioux; Richard H Duerr; Judy H Cho; Phil L Schumm; Mark Lazarev; Mark S Silverberg Journal: J Crohns Colitis Date: 2022-07-14 Impact factor: 10.020
Authors: Vipul Yadav; Yang Mai; Laura E McCoubrey; Yasufumi Wada; Motoyasu Tomioka; Satofumi Kawata; Shrikant Charde; Abdul W Basit Journal: Biomedicines Date: 2021-05-20